These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13653851)

  • 1. Growth of vaccinia virus in HeLa cells with special reference to the production of soluble antigens.
    TAGAYA I; ODA M
    Jpn J Med Sci Biol; 1958 Dec; 11(6):483-99. PubMed ID: 13653851
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of heated vaccinia virus on growth of vaccinia virus in Earle's L cells.
    GALASSO GJ; SHARP DG
    Proc Soc Exp Biol Med; 1961; 107():957-60. PubMed ID: 13896315
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of growth of the vaccinia virus by beta-2-thienylalanine and its reversal by phenylalanine.
    THOMPSON RL; WILKIN ML
    Proc Soc Exp Biol Med; 1948; 68(3):434-6. PubMed ID: 18884243
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth of vaccinia and variola viruses in the one-day-old fertile hen's egg.
    OYA A
    Jpn J Med Sci Biol; 1956 Dec; 9(6):293-302. PubMed ID: 13415771
    [No Abstract]   [Full Text] [Related]  

  • 5. The growth in vitro of vaccinia virus in chick embryo chorio-allantoic membrane, minced embryo and cell suspensions.
    MAITLAND HB; MAGRATH DI
    J Hyg (Lond); 1957 Sep; 55(3):347-60. PubMed ID: 13475780
    [No Abstract]   [Full Text] [Related]  

  • 6. The presence in mammalian liver and blood of substances which interfere with the growth of vaccinia virus. II. Testing of materials.
    DEDICHEN J; LALAND P; LALAND S; VOSS J
    Acta Med Scand; 1962 Jul; 172():121-8. PubMed ID: 13884794
    [No Abstract]   [Full Text] [Related]  

  • 7. The eclipse phase of vaccinia virus growing in chick embryo cell monolayers and some technical procedures which affect its demonstration.
    POSTLETHWAITE R; MAITLAND HB
    J Hyg (Lond); 1960 Jun; 58(2):133-45. PubMed ID: 14434421
    [No Abstract]   [Full Text] [Related]  

  • 8. The presence in mammalian liver and blood of substances which interfere with the growth of vaccinia virus. II. Methods for preparing biologically active materials and their chemical character.
    LALAND P; DEDICHEN J; LALAND S; THORSDALEN N
    Acta Med Scand; 1962 Jul; 172():117-20. PubMed ID: 14461677
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the anticomplement activity of antigens from normal HeLa cell cultures and those infected with vaccinia virus].
    WIGAND R
    Arch Gesamte Virusforsch; 1960; 10():139-49. PubMed ID: 13844684
    [No Abstract]   [Full Text] [Related]  

  • 10. STAINING OF VACCINIA ANTIGEN BY IMMUNOURANIUM TECHNIQUE.
    DONATI EJ; FIGGE FH; STERNBERGER LA
    Exp Mol Pathol; 1965 Feb; 4():126-9. PubMed ID: 14297548
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of skin resistance to vaccinia virus in rabbits by vaccinia-soluble early antigens.
    Ueda Y; Tagaya I
    J Exp Med; 1973 Nov; 138(5):1033-43. PubMed ID: 4744920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth cycle of vaccinia in HeLa cells correlated with concurrent cellular changes.
    RYDEN FW; RANDALL CC
    Am J Pathol; 1957; 33(3):367-83. PubMed ID: 13424651
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic alterations of nucleotides and nucleic acids in HeLa cells infected with vaccinia virus.
    NISHIMURA C; TAGAYA I
    Jpn J Med Sci Biol; 1959 Dec; 12():405-20. PubMed ID: 14402034
    [No Abstract]   [Full Text] [Related]  

  • 14. The synthesis of deoxyribonucleic acid by HeLa cells infected with vaccinia virus.
    MAGEE WE; SAGIK BP
    Virology; 1959 May; 8(1):134-7. PubMed ID: 13669333
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of three strains of vaccinia virus in stable cell strains L, LLC-M1, and HeLa.
    RYDEN FW; RANDALL CC
    Am J Pathol; 1957; 33(2):293-311. PubMed ID: 13402888
    [No Abstract]   [Full Text] [Related]  

  • 16. VACCINIA VIRUS-HELA CELL INTERACTION. II. THE EFFECT OF MITOMYCIN C ON THE PRODUCTION OF INFECTIVE VIRUS, COMPLEMENT-FIXING ANTIGEN, AND HEMAGGLUTININ.
    ODA M
    Virology; 1963 Dec; 21():533-9. PubMed ID: 14100602
    [No Abstract]   [Full Text] [Related]  

  • 17. VACCINIA VIRUS-HELA CELL INTERACTION. I. THE EFFECT OF IMMUNE SERUM ON THE PRODUCTION OF INFECTIVE VIRUS, COMPLEMENT-FIXING ANTIGEN, AND HEMAGGLUTININ.
    ODA M
    Virology; 1963 Aug; 20():552-8. PubMed ID: 14059822
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of various strains of vaccinia virus cultured on HeLa cells].
    GIL C; GARCIA AP; ALONSO ML; GALLARDO E
    Microbiol Esp; 1959; 12():401-8 contd. PubMed ID: 13849967
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.
    Ludwig H; Mages J; Staib C; Lehmann MH; Lang R; Sutter G
    J Virol; 2005 Feb; 79(4):2584-96. PubMed ID: 15681458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of the sequential development of vaccinial antigens and virus in infected cells: observations with cytochemical and differential fluorescent procedures.
    LOH PC; RIGGS JL
    J Exp Med; 1961 Jul; 114(1):149-60. PubMed ID: 13763191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.